Carlos Fernández Baltar
Research Subjects
Carlos Fernández Baltar has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Pérez Fentes
Endourology Unit, Urology Department University Hospital Complex of Santiago de Compostela A Coruña Spain
2 shared publications C. García-Freire
Department of Urology, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain
1 shared publicationD. Pérez Fentes
Complejo Universitario de Santiago de Compostela, Servicio de Urología, Santiago de Compostela, Spain
1 shared publicationF. Gude Sampedro
Complejo Universitario de Santiago de Compostela, Unidad de Epidemiología, Santiago de Compostela, Spain
1 shared publicationJ. F. Sánchez-García
Department of Urology, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain
1 shared publication- María Elena Martínez-Corral
Urology Department, Endourology Unit, University Hospital Complex of Santiago de Compostela, A Coruña, Spain.
1 shared publication
Latest Publications
- Open Access
- 10 September 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (9) , 962
Predicting and Avoiding Complications in Percutaneous Nephrolithotomy in the Era of Personalized Medicine: A Scoping Review
Background: Percutaneous nephrolithotomy (PCNL) is associated with a wide range of complications. This review aims to explore how recent technological advancements and personalized medicine can help prevent or predict these complications. Methods: A scoping review was conducted according to the PRISMA-SCR guidelines and registered on the Open Science Framework in April 2024. A literature search was performed on PUBMED, Web of Science, and Scopus databases. This review focused on predictive AI models, 3D surgical models, intrasurgical image guidance, and biomarkers. Articles meeting the following criteria were included: publication between 2019 and 2024, written in English, involving human participants, and discussing technological advancements or personalized medicine in the context of complications in PCNL. Results: Of the 11,098 articles searched, 35 new studies were included. We identified a few articles on predictive AI models. Several studies demonstrated that 3D presurgical models and virtual models could enhance surgical planning and reduce complications. New intrasurgical image and guidance systems showed the potential in reducing bleeding and radiation exposure. Finally, several biomarkers were identified as predictors of sepsis and other complications. Conclusion: This scoping review highlights the potential of emerging technologies in reducing and predicting PCNL complications. However, larger prospective studies are required for validation.
- 10 September 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (9) , 962
Open AccessPredicting and Avoiding Complications in Percutaneous Nephrolithotomy in the Era of Personalized Medicine: A Scoping Review
Background: Percutaneous nephrolithotomy (PCNL) is associated with a wide range of complications. This review aims to explore how recent technological advancements and personalized medicine can help prevent or predict these complications. Methods: A scoping review was conducted according to the PRISMA-SCR guidelines and registered on the Open Science Framework in April 2024. A literature search was performed on PUBMED, Web of Science, and Scopus databases. This review focused on predictive AI models, 3D surgical models, intrasurgical image guidance, and biomarkers. Articles meeting the following criteria were included: publication between 2019 and 2024, written in English, involving human participants, and discussing technological advancements or personalized medicine in the context of complications in PCNL. Results: Of the 11,098 articles searched, 35 new studies were included. We identified a few articles on predictive AI models. Several studies demonstrated that 3D presurgical models and virtual models could enhance surgical planning and reduce complications. New intrasurgical image and guidance systems showed the potential in reducing bleeding and radiation exposure. Finally, several biomarkers were identified as predictors of sepsis and other complications. Conclusion: This scoping review highlights the potential of emerging technologies in reducing and predicting PCNL complications. However, larger prospective studies are required for validation.
- 23 April 2024
- Published by Elsevier in Actas Urológicas Españolas
- Vol. 48 (8) , 603-610
¿Depende el éxito en nefrolitotomía percutánea solo del tamaño litiásico? Análisis de la capacidad predictiva de éxito y complicaciones de los actuales sistemas de puntuación de nefrolitometría y su relación con la superficie litiásica
- 23 April 2024
- Published by Elsevier in Actas Urológicas Españolas
- Vol. 48 (8) , 603-610
¿Depende el éxito en nefrolitotomía percutánea solo del tamaño litiásico? Análisis de la capacidad predictiva de éxito y complicaciones de los actuales sistemas de puntuación de nefrolitometría y su relación con la superficie litiásica
- 22 January 2018
- Published by Springer Nature in Urolithiasis
- Vol. 46 (6) , 581-585
Safety of percutaneous nephrolithotomy in patients on chronic anticoagulant or antiplatelet therapy
In developed countries, the incidence of cardiovascular disease is increasing, therefore, anticoagulant and antiplatelet drugs are a widespread treatment nowadays. Percutaneous nephrolithotomy (PNL) is the first-line treatment for large or complex stones (> 2 cm) and remains an alternative for the smaller ones. The objective of this study is to analyze whether PNL surgery is a safe procedure in patients under a treatment discontinuation protocol for anticoagulant or antiplatelet therapies. We retrospectively studied 301 patients who underwent PNL in our hospital between 2008 and 2016 and identified 46 patients on chronic antiplatelet or anticoagulation treatment. With respect to PNL outcomes, the stone-free rate was similar (78 vs 74%, p = 0.762) in both groups, without any significant differences in the overall postoperative complications (17 vs 26%, p = 0.203). The incidence of hemorrhagic complications was similar between groups (12 vs 9%, p = 0.492), as demonstrated by the mean drop in hemoglobin (Hb), which was comparable in both cohorts (2.2 ± 1.3 vs 2.0 ± 1.4 p = 0.270) and the blood transfusion rate (14% in group A and 8% in group B, p = 0.205). No thromboembolic events were found within the year after the PNL procedure. PNL is a safe and effective intervention in patients under a treatment discontinuation protocol for anticoagulant or antiplatelet therapies. Although our study demonstrates the feasibility of this protocol, new scientific evidence aims to stratify the thromboembolic and bleeding risk of each patient to individualize the perioperative management thereafter.
- 22 January 2018
- Published by Springer Nature in Urolithiasis
- Vol. 46 (6) , 581-585
Safety of percutaneous nephrolithotomy in patients on chronic anticoagulant or antiplatelet therapy
In developed countries, the incidence of cardiovascular disease is increasing, therefore, anticoagulant and antiplatelet drugs are a widespread treatment nowadays. Percutaneous nephrolithotomy (PNL) is the first-line treatment for large or complex stones (> 2 cm) and remains an alternative for the smaller ones. The objective of this study is to analyze whether PNL surgery is a safe procedure in patients under a treatment discontinuation protocol for anticoagulant or antiplatelet therapies. We retrospectively studied 301 patients who underwent PNL in our hospital between 2008 and 2016 and identified 46 patients on chronic antiplatelet or anticoagulation treatment. With respect to PNL outcomes, the stone-free rate was similar (78 vs 74%, p = 0.762) in both groups, without any significant differences in the overall postoperative complications (17 vs 26%, p = 0.203). The incidence of hemorrhagic complications was similar between groups (12 vs 9%, p = 0.492), as demonstrated by the mean drop in hemoglobin (Hb), which was comparable in both cohorts (2.2 ± 1.3 vs 2.0 ± 1.4 p = 0.270) and the blood transfusion rate (14% in group A and 8% in group B, p = 0.205). No thromboembolic events were found within the year after the PNL procedure. PNL is a safe and effective intervention in patients under a treatment discontinuation protocol for anticoagulant or antiplatelet therapies. Although our study demonstrates the feasibility of this protocol, new scientific evidence aims to stratify the thromboembolic and bleeding risk of each patient to individualize the perioperative management thereafter.